Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)
This study has been completed.
Study NCT01527383   Information provided by Merck

First Received on January 16, 2012.   Last Updated on March 26, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Herpes Zoster
Additional conditions recognized in this trial
Autoimmune Diseases
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Immune System Diseases
Virus Diseases
Interventions listed in this trial
V212
Placebo
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services